Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase I trial in Europe and sub-Saharan Africa (Vacc-iNTS)

The overall objective of Vacc-iNTS is to bridge the gap between preclinical and early clinical development of a novel vaccine against invasive non-typhoidal salmonellosis (iNTS), based on GMMA (Generalized Modules for Membrane Antigens) technology and to conduct a Phase I study to demonstrate safety and immunogenicity of the iNTS-GMMA candidate vaccine in healthy European and African adults.

Project type:Samenwerkingsproject